2012
DOI: 10.4236/jcdsa.2012.22020
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Comparison between Sun Irradiation vs. Narrowband UVB Phototherapy along with Concomitant Topical Tacalcitol for Vitiligo Vulgaris

Abstract: In addition to therapeutic options such as steroid ointment, immunosuppressive drug and ultraviolet phototherapy, recent reports have demonstrated the clinical efficacy of topical vitamin D3 for vitiligo vulgaris. However, there seems to be little clinical effect of vitamin D3 without UV exposure. In the present study, we evaluated the clinical difference of sun irradiation vs. narrowband UVB in combination with tacalcitol assessing the change of lesion size and color tone by a spectrophotometer. Thirty-three … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
1
0
0
Order By: Relevance
“…We used a spectrophotometer to measure the color changes determined according to the Lab score before and after the administration of steroid therapy. The device was useful to calculate the white contrast when we compared therapeutic effect between narrowband UVB and sun irradiation in addition to topical tacalcitol [10]. The delta L score exhibited a tendency to decrease after treatment in the patients who achieved disease arrest not disease progression or recurrence, as expected.…”
Section: Discussionsupporting
confidence: 53%
“…We used a spectrophotometer to measure the color changes determined according to the Lab score before and after the administration of steroid therapy. The device was useful to calculate the white contrast when we compared therapeutic effect between narrowband UVB and sun irradiation in addition to topical tacalcitol [10]. The delta L score exhibited a tendency to decrease after treatment in the patients who achieved disease arrest not disease progression or recurrence, as expected.…”
Section: Discussionsupporting
confidence: 53%